L. Fabbri (Modena, Italy), E. Russi (Zurich, Switzerland)
Early discharge for patients with exacerbations of COPD - a real life cohort study
G. E. Seebass, P. K. Plant, V. Walker (Leeds, United Kingdom)
|   |
The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
H. S. R. Hosker, K. Anstey, D. Lowe, M. Pearson, M. C. Roberts (London, United Kingdom)
| |
The effect of unit organisation and resources on outcomes of hospital admission for COPD exacerbations
H. S. R. Hosker, K. Anstey, D. Lowe, M. Pearson, M. C. Roberts (London, United Kingdom)
| |
The hospital management of COPD exacerbations in the UK: does it conform to national guidance?
H. S. R. Hosker, K. Anstey, D. Lowe, M. Pearson, M. C. Roberts (London, United Kingdom)
| |
Elevation of cardiac enzymes in COPD patients with respiratory failures
E. C. Seyhan, S. Altin, E. Cetinkaya, K. Epozturk, S. Timur (Istanbul, Turkey)
| |
Clinical value of C-reactive protein in severe acute exacerbations of COPD
J. M. Daniels, C. S. de Graaff, F. Vlaspolder, W. G. Boersma (Alkmaar, Netherlands)
| |
Time course of sputum and serum interleukin-6 during COPD exacerbations
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |
Procalcitonin-guided antibiotic therapy in acute exacerbations of COPD (AECOPD): a randomised trial - The ProCOLD Study
D. Stolz, M. Christ-Crain, R. Bingisser, M. Gencay, J. Leuppi, D. Miedinger, C. Müller, P. Huber, B. Müller, M. Tamm (Basel, Switzerland)
| |